Does Covered California Cover Weight Loss Drugs?

Some Covered California plans do cover weight loss drugs, but coverage is never guaranteed and never automatic. Whether your marketplace plan will pay for a medication like Wegovy, Zepbound, or Saxenda depends on which carrier you enrolled with, your body mass index, and whether you are willing to enroll in a structured weight management program. Nearly every carrier that offers any coverage requires prior authorization, and several major carriers exclude these drugs entirely when prescribed for weight loss alone.

Which Covered California Carriers Cover Weight Loss Drugs

Covered California is the state’s marketplace for private health plans. Each participating carrier sets its own formulary and its own rules for anti-obesity medications, so the answer to whether your plan covers a GLP-1 or another weight loss drug depends entirely on who issued the plan.

Health Net

Health Net covers weight loss medications for its Individual and Family Plan members, including Covered California enrollees, effective January 1, 2026. Members with a BMI of 40 or higher qualify with prior authorization and enrollment in a Health Net-approved program such as Weight Watchers. For a BMI between 30 and 40, coverage depends on the specific plan, and providers must verify benefits before prescribing. Patients already on a GLP-1 or other weight loss drug with a BMI of 30 or above can keep their coverage as long as the prescription continues and the patient stays in an approved program.¹

Covered drugs include the injectables Wegovy, Zepbound, and Saxenda, along with oral options like phentermine, Qsymia, Contrave, and Xenical. All require prior authorization.¹

Blue Shield of California

Blue Shield generally excludes weight loss medications when prescribed solely for weight loss. The exception is Class III (morbid) obesity, and even then coverage requires prior authorization showing medical necessity plus participation in a comprehensive weight loss program that includes a reduced-calorie diet, physical activity, and behavior therapy, both before and during medication use.² Members who don’t meet these criteria pay full cost.³

Kaiser Permanente

Kaiser’s California commercial formularies cover drugs when a Kaiser physician or authorized referral doctor deems them medically necessary, and the formulary documents note no general prior authorization or step therapy requirements.⁴ Broker reporting indicates Kaiser limits GLP-1 access for weight loss to up to 24 months for members who started with a BMI of 40 or above.⁵ Members should confirm through their Evidence of Coverage or Member Services.

Other Carriers

Coverage across the remaining Covered California carriers varies widely:⁵

Anthem classifies GLP-1 weight loss drugs as Tier 4 specialty and non-formulary, requiring prior authorization and generally processing them as plan exclusions.
UnitedHealthcare covers weight loss drugs for California fully insured groups with a BMI of 30 or higher, or 27 with a comorbidity, along with wellness program participation and prior authorization. Medications generally sit on Tier 3.
Sutter Health Plan covers GLP-1s for morbid obesity but requires six months of active engagement in the Vida weight management program before coverage begins. Wegovy and Zepbound are non-formulary Tier 4.
Western Health Advantage covers weight loss drugs at a BMI above 40 through prior authorization or non-formulary exception, with approved drugs defaulting to the highest cost-share tier.
Aetna covers weight loss drugs on ACA-compliant plans but excludes them from Aetna Funding Advantage plans.
MediExcel and Prominence Health Plan do not cover GLP-1s for weight loss.

What You’ll Typically Need to Get Approved

Across nearly every Covered California carrier that offers any coverage, approval hinges on a similar set of steps. Prior authorization is nearly universal: your prescriber has to submit documentation showing the medication is medically necessary before the insurer will pay. Beyond that, expect some combination of the following:

A qualifying BMI. Most plans require at least a BMI of 40 for new prescriptions. Some set the bar at 30, or at 27 with a weight-related condition such as high blood pressure or sleep apnea.
Enrollment in a structured weight management program that includes a reduced-calorie diet, physical activity, and behavioral counseling. Some carriers require six months of participation before the drug is approved.
Step therapy, meaning you try and fail on a less expensive medication first.
Clinical documentation: current weight and BMI, relevant labs, records of prior weight loss attempts, and documentation of any obesity-related conditions.

More than 88% of commercially insured people with coverage for GLP-1 weight loss drugs face at least one of these restrictions.⁶ If a claim is denied, you can appeal, and denials are sometimes overturned when missing documentation is supplied or a prescriber writes a letter of medical necessity.⁷

How to Check Your Specific Plan

Because rules differ so much between carriers, check your own plan’s formulary and Evidence of Coverage before assuming anything. Covered California offers a prescription lookup tool where you can review whether a specific medication appears in your plan’s drug list.⁸ Each plan organizes drugs into four tiers — generic, preferred, non-preferred, and specialty — and your cost depends on both the tier and your plan’s metal level.

For weight loss drugs in particular, call the carrier’s provider services or pharmacy department before a prescription is written. That call can confirm whether prior authorization is required, what BMI threshold applies, and whether a weight management program is a prerequisite. If a claim is denied, request the appeal process in writing, and ask your prescriber to document medical necessity along with prior weight loss efforts.

Medi-Cal Does Not Cover These Drugs for Adults

If your household income is low enough that you might be in Medi-Cal rather than Covered California, the rules are different, and the difference matters. Medi-Cal is California’s separate public insurance program for lower-income residents. People apply for both through the same application and can move between them as income changes.⁹

Effective January 1, 2026, Medi-Cal stopped covering GLP-1 medications when prescribed for weight loss for members age 21 and older. The affected drugs are Wegovy, Saxenda, and Zepbound. Claims with a weight-loss indication are now denied, and prior authorizations in place before the cutoff expired on December 31, 2025.¹⁰ The change applies to both Medi-Cal fee-for-service and all Medi-Cal managed care plans.¹¹

Medi-Cal still covers GLP-1s for other FDA-approved uses. Ozempic, Rybelsus, Mounjaro, Victoza, Byetta, Bydureon, and Trulicity remain covered for type 2 diabetes with the appropriate diagnosis code. Wegovy can be covered for cardiovascular disease or noncirrhotic MASH with proper documentation. Zepbound may be covered for obstructive sleep apnea through prior authorization.¹² Members under 21 may still qualify through the federal EPSDT benefit with an approved prior authorization.¹³

If a Medi-Cal claim is denied, the member receives a Notice of Action and can request a state hearing through the California Department of Social Services within 90 days. To keep receiving medication while the hearing is pending, the hearing request must be filed within 10 days of the denial notice.¹³

Pending Legislation Could Change Private Plan Rules

California lawmakers have tried more than once to require private insurers to cover anti-obesity medications. Assembly Bill 575, the Obesity Prevention Treatment Parity Act, would have required state-regulated health plans to cover at least one GLP-1 anti-obesity medication and intensive behavioral therapy without prior authorization. The bill failed to advance out of the Assembly Health Committee and was formally filed with the Chief Clerk on February 2, 2026.¹⁴

Senate Bill 535 is still active. Sponsored by the Chronic Obesity Prevention and Education (cHOPE) Alliance, it would require health plans to cover bariatric surgery and at least one FDA-approved anti-obesity medication for chronic weight management. SB 535 does not ban prior authorization, but it does prohibit coverage criteria from being more restrictive than FDA-approved indications, and it would not compel plans to cover a GLP-1 specifically. A non-GLP-1 anti-obesity drug could satisfy the requirement.¹⁵ As of August 2025, SB 535 was scheduled for a hearing before the Assembly Appropriations Committee. If enacted, it would apply to roughly 13.6 million enrollees in state-regulated commercial and CalPERS plans, but not to Medi-Cal beneficiaries.¹⁶

1
Health Net California Provider Library. Weight Loss Medications Coverage Criteria, Effective January 2026
2
Blue Shield of California. Weight Loss Drug Exclusion Fact Sheet
3
Blue Shield of California. Pharmacy Benefits Policy
4
Kaiser Permanente. 2026 Southern California Commercial HMO Formulary
5
Word & Brown. Weight Loss Drugs (GLP-1) Coverage
6
GoodRx. Tracking Insurance Coverage Weight Loss Meds
7
GoodRx. GLP-1 Prior Authorization Criteria
8
Covered California. Prescriptions
9
Covered California. Covered California and Medi-Cal Difference
10
Medi-Cal Rx (DHCS). Important Update: GLP-1s Weight Loss Not Covered Benefit
11
California Medical Association. GLP-1 Medications for Weight Loss Will No Longer Be Covered by Medi-Cal
12
Medi-Cal Rx (DHCS). Members State Budget Policy Updates FAQ
13
Medi-Cal Rx (DHCS). GLP-1 Weight Loss Member Letter
14
CalMatters Digital Democracy. AB 575
15
California Senate Budget Committee. SB 535 Analysis
16
CHBRP. SB 535 Obesity Treatment Analysis